These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6467036)

  • 21. Cholinergic stimulation of rostral and caudal substantia nigra pars compacta produces opposite effects on circling behavior and striatal dopamine release measured by brain microdialysis.
    Hernández-López S; Góngora-Alfaro JL; Martínez-Fong D; Rosales MG; Aceves J
    Neuroscience; 1994 Sep; 62(2):441-7. PubMed ID: 7830890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Striatal dopamine-glutamate interactions reflected in substantia nigra reticulata firing.
    Timmerman W; Westerhof F; van der Wal TI; Westerink BH
    Neuroreport; 1998 Dec; 9(17):3829-36. PubMed ID: 9875713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose-regulated dopamine release from substantia nigra neurons.
    Levin BE
    Brain Res; 2000 Aug; 874(2):158-64. PubMed ID: 10960600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system.
    Javoy F; Sotelo C; Herbet A; Agid Y
    Brain Res; 1976 Feb; 102(2):201-15. PubMed ID: 1247882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatal nitric oxide signaling regulates the neuronal activity of midbrain dopamine neurons in vivo.
    West AR; Grace AA
    J Neurophysiol; 2000 Apr; 83(4):1796-808. PubMed ID: 10758092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SCH 23390, a selective D1 dopamine receptor blocker, enhances the firing rate of nigral dopaminergic neurons but fails to activate striatal tyrosine hydroxylase.
    Onali P; Mereu G; Olianas MC; Bunse B; Rossetti Z; Gessa GL
    Brain Res; 1985 Aug; 340(1):1-7. PubMed ID: 2862956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism.
    Schmidt RH; Björklund A; Stenevi U; Dunnett SB; Gage FH
    Acta Physiol Scand Suppl; 1983; 522():19-28. PubMed ID: 6326471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
    Koulu M; Sjöholm B; Lappalainen J; Virtanen R
    Eur J Pharmacol; 1989 Oct; 169(2-3):321-4. PubMed ID: 2530097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the release of dopamine from medial prefrontal cortex modulated by presynaptic receptors? Comparison with nigrostriatal and mesolimbic terminals.
    Cubeddu LX; Hoffmann IS; Talmaciu RK
    Ann N Y Acad Sci; 1990; 604():452-61. PubMed ID: 2171402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats.
    Meissner W; Harnack D; Reese R; Paul G; Reum T; Ansorge M; Kusserow H; Winter C; Morgenstern R; Kupsch A
    J Neurochem; 2003 May; 85(3):601-9. PubMed ID: 12694386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons.
    Kerkerian L; Salin P; Nieoullon A
    Neuroscience; 1988 Sep; 26(3):809-17. PubMed ID: 3143926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMDA receptor blockade increases in vivo striatal dopamine synthesis and release in rats and mice with incomplete, dopamine-depleting, nigrostriatal lesions.
    Richard MG; Bennett JP
    J Neurochem; 1995 May; 64(5):2080-6. PubMed ID: 7722491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Centrally acting muscle relaxants in tetanus.
    WEBSTER RA
    Br J Pharmacol Chemother; 1961 Dec; 17(3):507-18. PubMed ID: 14005498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
    Santiago M; Rollema H; de Vries JB; Westerink BH
    Brain Res; 1991 Jan; 538(2):226-30. PubMed ID: 1707325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological, biochemical, and behavioral studies of acute haloperidol-induced depolarization block of nigral dopamine neurons.
    Hollerman JR; Abercrombie ED; Grace AA
    Neuroscience; 1992; 47(3):589-601. PubMed ID: 1584410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
    Santiago M; Westerink BH
    Eur J Pharmacol; 1991 Oct; 204(1):79-85. PubMed ID: 1687125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons.
    Hollerman JR; Grace AA
    Brain Res; 1990 Nov; 533(2):203-12. PubMed ID: 2126975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of para-chlorophenylalanine on amphetamine and haloperidol-induced changes in striatal dopamine turnover.
    Kuczenski R
    Brain Res; 1979 Mar; 164():217-25. PubMed ID: 154937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nigrostriatal cell firing action on the dopamine transporter.
    Rodriguez M; Gonzalez S; Morales I; Sabate M; Gonzalez-Hernandez T; Gonzalez-Mora JL
    Eur J Neurosci; 2007 May; 25(9):2755-65. PubMed ID: 17561841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Firing properties of substantia nigra dopaminergic neurons in freely moving rats.
    Freeman AS; Meltzer LT; Bunney BS
    Life Sci; 1985 May; 36(20):1983-94. PubMed ID: 3990520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.